VJHemOnc Podcast The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation
Jul 28, 2020
Experts discuss treating hematologic malignancies during the COVID-19 pandemic, reducing nosocomial COVID-19 infections, clinical trial participation, and resource allocation. They highlight challenges in patient management, resource distribution, and the use of telemedicine. The impact on clinical trials, treatment considerations, and the need for international collaboration are also discussed.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Treating Hematologic Malignancies during the COVID-19 Pandemic
01:32 • 9min
The Impact of COVID-19 on Resource Allocation and Patient Care
10:32 • 4min
Telemedicine in Managing Hematologic Malignancies during COVID-19
14:21 • 12min
Choosing and Prioritizing Clinical Trials During the COVID-19 Pandemic
26:10 • 7min
Treatment Considerations for Hematological Malignancies and COVID-19
33:27 • 20min
Individualized Care and International Collaboration in the COVID-19 Pandemic
53:55 • 3min